Susquehanna International Group, LLP Neurocrine Biosciences Inc Put Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Put Options

29 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$114.58 - $153.15 $9.07 Million - $12.1 Million	79,200 Added 100.0%	158,400 $18.2 Million
Q2 2024 Aug 15, 2024	SELL	$130.86 - $143.19 $4 Million - $4.38 Million	-30,600 Reduced 27.87%	79,200 $10.9 Million
Q1 2024 May 07, 2024	BUY	$130.4 - $143.74 $1.97 Million - $2.17 Million	15,100 Added 15.95%	109,800 $15.1 Million
Q4 2023 Feb 14, 2024	BUY	$106.07 - $132.76 $201,533 - $252,243	1,900 Added 2.05%	94,700 $12.5 Million
Q3 2023 Nov 14, 2023	BUY	$94.02 - $117.1 $5.66 Million - $7.05 Million	60,200 Added 184.66%	92,800 $10.4 Million
Q2 2023 Aug 11, 2023	SELL	$89.53 - $104.87 $4.69 Million - $5.5 Million	-52,400 Reduced 61.65%	32,600 $3.07 Million
Q1 2023 May 16, 2023	BUY	$94.11 - $123.02 $7.48 Million - $9.78 Million	79,500 Added 1445.45%	85,000 $8.6 Million
Q4 2022 Feb 14, 2023	SELL	$106.72 - $127.06 $1.28 Million - $1.52 Million	-12,000 Reduced 68.57%	5,500 $656,000
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $266,887 - $312,649	2,900 Added 19.86%	17,500 $1.86 Million
Q2 2022 Aug 15, 2022	SELL	$75.79 - $100.07 $4.21 Million - $5.55 Million	-55,500 Reduced 79.17%	14,600 $1.42 Million
Q1 2022 May 16, 2022	BUY	$72.45 - $94.81 $883,890 - $1.16 Million	12,200 Added 21.07%	70,100 $6.57 Million
Q4 2021 Feb 14, 2022	BUY	$79.65 - $106.22 $2.19 Million - $2.92 Million	27,500 Added 90.46%	57,900 $4.93 Million
Q3 2021 Nov 15, 2021	SELL	$86.18 - $99.03 $2.39 Million - $2.74 Million	-27,700 Reduced 47.68%	30,400 $2.92 Million
Q2 2021 Aug 11, 2021	SELL	$89.43 - $102.27 $98,373 - $112,497	-1,100 Reduced 1.86%	58,100 $5.65 Million
Q1 2021 May 17, 2021	SELL	$87.57 - $119.4 $7.29 Million - $9.93 Million	-83,200 Reduced 58.43%	59,200 $5.76 Million
Q4 2020 Feb 16, 2021	SELL	$86.91 - $108.33 $1.51 Million - $1.88 Million	-17,400 Reduced 10.89%	142,400 $13.6 Million
Q3 2020 Nov 16, 2020	BUY	$96.16 - $135.15 $2.31 Million - $3.24 Million	24,000 Added 17.67%	159,800 $15.4 Million
Q2 2020 Aug 14, 2020	BUY	$85.09 - $130.36 $3.8 Million - $5.83 Million	44,700 Added 49.07%	135,800 $16.6 Million
Q1 2020 May 15, 2020	BUY	$75.11 - $113.76 $630,924 - $955,584	8,400 Added 10.16%	91,100 $7.89 Million
Q4 2019 Feb 14, 2020	SELL	$86.8 - $118.57 $6.27 Million - $8.56 Million	-72,200 Reduced 46.61%	82,700 $8.89 Million
Q3 2019 Nov 14, 2019	BUY	$83.82 - $101.5 $2.85 Million - $3.45 Million	34,000 Added 28.12%	154,900 $14 Million
Q2 2019 Aug 14, 2019	SELL	$72.24 - $91.27 $910,223 - $1.15 Million	-12,600 Reduced 9.44%	120,900 $10.2 Million
Q1 2019 May 15, 2019	SELL	$69.31 - $91.53 $526,756 - $695,628	-7,600 Reduced 5.39%	133,500 $11.8 Million
Q4 2018 Feb 14, 2019	SELL	$68.32 - $124.36 $3.57 Million - $6.49 Million	-52,200 Reduced 27.0%	141,100 $10.1 Million
Q3 2018 Nov 14, 2018	SELL	$98.88 - $125.85 $247,200 - $314,625	-2,500 Reduced 1.28%	193,300 $23.8 Million
Q2 2018 Aug 14, 2018	BUY	$75.3 - $105.99 $6.47 Million - $9.1 Million	85,900 Added 78.16%	195,800 $19.2 Million
Q1 2018 May 15, 2018	SELL	$75.88 - $92.43 $4.06 Million - $4.95 Million	-53,500 Reduced 32.74%	109,900 $9.11 Million
Q4 2017 Feb 14, 2018	BUY	$58.53 - $77.59 $386,298 - $512,094	6,600 Added 4.21%	163,400 $12.7 Million
Q3 2017 Nov 14, 2017	BUY	$47.97 - $61.28 $7.52 Million - $9.61 Million	156,800	156,800 $9.61 Million

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$1.92 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.35 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$697 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$349 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$252 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account